NCT02508480

Brief Summary

We are conducting a randomized clinical trial (RCT) comparing the 10-week peer-led Photovoice program to services as usual (SAU) at a large publicly funded community mental health agency in Massachusetts. The control SAU condition will be enhanced with a 60-minute peer-led group educational session about understanding and coping with prejudice and discrimination. The 10-session, peer-led Photovoice program, designed to empower individuals with serious mental illness (SMI) to confront public prejudice and discrimination and reduce personal stigma (self-stigma and perceived stigma), was developed and pilot tested at our Center, with primary contributions from staff with a lived experience of mental illness. Development of the Photovoice program was guided by an adaptation of the stress-coping model, informed by recent research and conceptualizations of the effects of stigma on people with SMI. The stress-coping model explicates the mechanisms by which public stigma about mental illness can lead to personal stigma, which in turn has a negative impact on the person's mental health and psychosocial functioning. This model also identifies critical factors that contribute to personal stigma or protect against it, as well as more vs. less adaptive coping responses, that are the primary focus of the Photovoice program.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
192

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 5, 2015

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 23, 2015

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 27, 2015

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 15, 2019

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

April 10, 2020

Completed
Last Updated

April 10, 2020

Status Verified

March 1, 2020

Enrollment Period

4 years

First QC Date

July 23, 2015

Results QC Date

February 12, 2020

Last Update Submit

March 30, 2020

Conditions

Keywords

StigmaCommunity Integration

Outcome Measures

Primary Outcomes (5)

  • Internalized Stigma of Mental Illness Scale, Change in Internalized Stigma

    a 29-item, 4-point scale (strongly disagree to strongly agree) assesses behaviors, thoughts and feelings that are self-stigmatizing and includes alienation, stereotype endorsement, discriminatory experiences, social withdrawal, and stigma resistance subscales. Internal consistency is .9 and test-retest reliability is .92. Lower scores are better. The scale score is the average score on the 29 items, which are scored from 1-4. Lower scores signify less internalized stigma.

    Baseline, post-treatment, 3 months post-treatment, 6 months post-treatment

  • Approaches to Coping With Stigma, Change in Coping With Stigma

    is a 27-item, 4-point scale ranging from 1-4 (strongly disagree to strongly agree) measuring strategies to cope with stigma: secrecy, withdrawal, distancing, educating others, and challenging others. The average score of the items in the first three subscales will represent the index for Avoidant Coping and the average score of the items in the last two subscales - the index for Proactive Coping with Stigma. Internal consistency for subscales range: .63-.84. Lower scores are better on Avoidant Coping and higher scores are better on Proactive Coping.

    Baseline, post-treatment, 3 months post-treatment, 6 months post-treatment

  • The Stigma Scale, Change in Perceptions of Stigma

    is a 28 item, 5 point scale ranging from 0-4 (strongly disagree to strongly agree) measuring experienced and anticipated stigma. Internal consistency ranges from .85-.87 and test-retest reliability from .4 to .7. The scale score is the average score on all items. Lower scores are better.

    Baseline, post-treatment, 3 months post-treatment, 6 months post-treatment

  • Heinrich's Quality of Life Scale-Client Version, Change in Quality of Life

    This is a 21 item, semi-structured interview-based, rating of an individual's psycho-social functioning and satisfaction with various life domains. The score on each item ranges from 0-6 with higher scores indicating better functioning. The subscale scores are computed based on the average score of items included. We report below on the interpersonal functioning and intrapsychic foundations subscales.

    Baseline, post-treatment, 3 months post-treatment, 6 months post-treatment

  • Temple University Community Participation Scale, Change in Community Participation

    is a 26 item instrument measuring frequency of participation and importance of various community activities (e.g., movies, library). Test-retest reliability is .7 and internal consistency is .9. Higher scores are better. We provide below the results for cumulative days of participation in the last 30 days across the 26 activities included in the measure (tcpm\_days\_participated). The possible range for this measure is 0-780.

    Baseline, post-treatment, 3 months post-treatment, 6 months post-treatment

Secondary Outcomes (4)

  • Brief Psychiatric Rating Scale, Change in Psychiatric Symptoms

    Baseline, post-treatment, 3 months post-treatment, 6 months post-treatment

  • Scales of Psychological Well-Being, Change in Well-being

    Baseline, post-treatment, 3 months post-treatment, 6 months post-treatment

  • Maryland Assessment of Recovery, Change in Perceptions of Recovery

    Baseline, post-treatment, 3 months post-treatment, 6 months post-treatment

  • Personal Growth and Recovery Scale, Change in Perceptions of Growth and Recovery

    Baseline, post-treatment, 3 months post-treatment, 6 months post-treatment

Study Arms (2)

Photovoice

EXPERIMENTAL

Participants in this arm will attend a 10-week peer-led Photovoice program conducted in group format.

Behavioral: Photovoice

Enhanced Control

ACTIVE COMPARATOR

Participants in this arm will attend a 60-minute peer-led group discussion on stigma and discrimination, and be eligible to participate in the 10-week Photovoice program after completing all study assessments.

Behavioral: Enhanced Control

Interventions

PhotovoiceBEHAVIORAL

The 10-session, peer-led Photovoice program, designed to empower individuals with SMI to confront public prejudice and discrimination and reduce personal stigma (self-stigma and perceived stigma), was developed and pilot tested at our Center, with primary contributions from staff with a lived experience of mental illness. In the Photovoice sessions, participants will be given a workbook titled Combating Prejudice and Discrimination through Photovoice Empowerment. Peer leaders will facilitate discussions based on topics in the workbook. Participants will be given cameras and guidance on taking pictures and writing narratives descriptions about the pictures, specifically the ways in which the pictures relate to experiences of prejudice and discrimination.

Photovoice

The control SAU condition will be enhanced with a 60-minute peer-led manualized educational group session (Leaders' Guidelines and Handout for Participants are attached). It will provide participants with information about the nature of stigma and the laws in the U.S. that protect people with disabilities from discrimination. Participants will be engaged in a discussion about their use of different strategies for proactive coping with psychiatric stigma. This session will be co-led by the same peers who will be delivering the Photovoice program to the experimental group at relevant wave and study sites. Participants randomized to the enhanced Services as Usual control condition will be invited to join a Photovoice group once they complete the final 6-month follow-up assessment.

Enhanced Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18years and older
  • Diagnosis of serious mental illness
  • Receiving services at agency where study is taking place
  • Willing and able to give written consent
  • Conversant in English

You may not qualify if:

  • Prior exposure to Photovoice
  • Cognitive disability

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Boston University

Boston, Massachusetts, 02215, United States

Location

MeSH Terms

Conditions

Mental DisordersSocial Stigma

Condition Hierarchy (Ancestors)

Social BehaviorBehavior

Results Point of Contact

Title
Dr. Zlatka Russinova
Organization
Boston University

Study Officials

  • Zlatka Russinova, PhD

    Boston University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Associate Professor

Study Record Dates

First Submitted

July 23, 2015

First Posted

July 27, 2015

Study Start

March 5, 2015

Primary Completion

February 15, 2019

Study Completion

February 15, 2019

Last Updated

April 10, 2020

Results First Posted

April 10, 2020

Record last verified: 2020-03

Locations